Year In Review: Most Impactful Regulatory Developments In 2024
From EU Pharma Review To Global Framework For Nitrosamine Impurities. What’s Next?
We review the most notable regulatory developments of the past year, with experts outlining for Generics Bulletin the regulatory to-do list for 2025.
